Reusable Syringe Market Global Report 2026

The reusable syringe market size has grown strongly in recent years. It will grow from $2.24 billion in 2025 to $2.43 billion in 2026 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to rising healthcare spending, expanded utilization of reusable medical devices, increased emphasis on minimizing medical waste, scaling of immunization programs, and economic benefits from multi-use devices.

The reusable syringe market size is expected to see strong growth in the next few years. It will grow to $3.34 billion in 2030 at a compound annual growth rate (CAGR) of 8.3%. The growth over the forecast period can be attributed to advancements in durable syringe material technologies, increasing demand for sustainable healthcare product alternatives, growing adoption across emerging healthcare markets, expansion of research and diagnostic laboratory activities, and strengthening of sterilization and infection control infrastructure. Major trends during the forecast period include rising adoption of sterilizable long-life syringe materials, growing demand for reusable syringes in cost-sensitive healthcare environments, increasing preference for safety-engineered reusable syringe designs, expansion of reusable syringe usage in veterinary and laboratory applications, and enhanced focus on reducing medical waste through reusable injection device adoption.

The growing emphasis on minimizing medical waste is expected to drive the growth of the reusable syringe market going forward. Medical waste refers to any form of waste generated from healthcare activities, including used syringes, bandages, medical equipment, and contaminated materials that may present health or environmental hazards. The increasing focus on reducing medical waste is being driven by rising environmental concerns and stricter regulatory frameworks, as healthcare systems aim to reduce pollution, enhance safety, and adopt sustainable waste management approaches. Efforts to reduce medical waste are boosting the adoption of reusable syringes by encouraging healthcare providers to shift toward durable, sterilizable alternatives that reduce single-use plastic waste and enhance sustainability in healthcare practices. For instance, in March 2023, according to NHS Digital, a UK government health data and statistical authority, providers generate around 156,000 tonnes of clinical waste annually, which is either processed through high-temperature incineration (HTI) or alternative treatment (AT), a quantity equivalent to more than 400 fully loaded jumbo jets of waste. Therefore, the rising focus on reducing medical waste is driving the growth of the reusable syringe market.

Key companies operating in the reusable syringe market are focusing on developing innovative products, such as over-the-counter (OTC) reusable enteral syringes to improve medication and feeding delivery efficiency. Reusable syringes are medical-grade injection or delivery devices designed for multiple uses after proper cleaning and sterilization, offering durable construction, accurate dosage measurement, and compatibility with enteral feeding systems such as ENFit connectors. For example, in January 2026, ENvue Medical Inc., a US-based medical device company, launched a new line of OTC ENFit reusable syringes designed for both enteral feeding and medication delivery applications. The product line is available in multiple sizes, including 2.5 mL, 5 mL, 10 mL, and 60 mL variants, and is designed for prescription-free access through online retail platforms and durable medical equipment channels. These syringes are engineered to ensure secure ENFit-compatible connections, improved dosing accuracy, and ease of use in homecare settings, supporting safer and more efficient patient-managed enteral nutrition and medication administration.

In January 2026, ENvue Medical Inc., a US-based medical technology company focused on manufacturing reusable ENFit syringes, entered into a partnership with U-Deliver to broaden the distribution of its ENFit syringe offerings across home care and long-term care markets in the United States. Through this collaboration, ENvue Medical and U-Deliver plan to utilize U-Deliver’s digital platform and wholesale distribution network to enhance availability of ENvue’s ENFit syringes, which are designed to ensure safe and consistent enteral feeding and medication administration in both clinical and home-care settings without the need for a prescription. U-Deliver LLC is a US-based supplier and distributor of enteral feeding products for home healthcare and long-term care environments.

Major companies operating in the reusable syringe market are Sanofi S.A., Novo Nordisk A/S, Eli Lilly and Company, Neogen Corporation, Gerresheimer AG, Datwyler Holding Inc., Ypsomed Holding AG, SHL Medical AG, Trajan Scientific and Medical, Hamilton Company, Vygon SA, Nemera France SAS, Owen Mumford Ltd., Cadence Inc., Henke Sass Wolf GmbH, Jørgen Kruuse UK Ltd., ENvue Medical (USA) Inc., Socorex Isba SA, ARDES Group, Portal Instruments Inc.

North America was the dominant region in the reusable syringe market in 2025. Asia-Pacific is expected to be the rapidly expanding region in the forecast period. The regions covered in reusable syringe report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the reusable syringe market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The reusable syringe market consists of sales of reusable syringe barrels, syringe assemblies, precision dosing syringes, multi-use injection syringes, autoclavable syringes, calibrated reusable syringes, and reusable fluid administration syringes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The reusable syringe market research report is one of a series of new reports that provides reusable syringe market statistics, including reusable syringe industry global market size, regional shares, competitors with a reusable syringe market share, detailed reusable syringe market segments, market trends and opportunities, and any further data you may need to thrive in the reusable syringe industry. This reusable syringe market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

This product will be delivered within 1-3 business days.